CFA
NEO icon

Carroll Financial Associates’s NeoGenomics NEO Stock Holding History

Carroll Financial Associates’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$3K Hold
100
– – ﹤0.01% 1441
2021
Q3 		$4K Hold
100
– – ﹤0.01% 1429
2021
Q2 		$4K Sell
100
-300
-75% -$13.3K ﹤0.01% 1484
2021
Q1 		$19K Sell
400
-200
-33% -$10.4K ﹤0.01% 1044
2020
Q4 		$32K Hold
600
– – ﹤0.01% 806
2020
Q3 		$22K Sell
600
-425
-41% -$15.8K ﹤0.01% 834
2020
Q2 		$31K Buy
+1,025
New +$28.4K ﹤0.01% 768

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Carroll Financial Associates's NEO Position: Q4 2021 in Review

Carroll Financial Associates held its NeoGenomics (NEO) position steady in Q4 2021 at 100 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1441.

Carroll Financial Associates first reported a position in NEO in Q2 2020 and has held it in 7 quarters since. The position peaked at $32K in Q4 2020. 309 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • Carroll Financial Associates held 100 shares of NeoGenomics worth $3K as of Q4 2021.
  • Carroll Financial Associates left its NeoGenomics share count unchanged in Q4 2021.
  • NeoGenomics made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1441 holding.
  • Carroll Financial Associates first reported a position in NeoGenomics in Q2 2020 and has held it in 7 quarters since.
  • Carroll Financial Associates's NeoGenomics position peaked at $32K in Q4 2020.
  • 309 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.